Working to Increase Awareness of Heparin-Induced Thrombocytopenia (HIT)
Heparin-induced thrombocytopenia (HIT) is a serious complication that has potentially devastating consequences. Despite a number of new therapies, research has shown that HIT is not always detected or managed optimally in hospital settings. This initiative will provide health care professionals who treat patients receiving heparin anticoagulation education on HIT risk factors, presentation, diagnosis and management, as well as for timely information on new and emerging therapeutic options.
Learning Objectives
- Identify risk factors associated with heparin-induced thrombocytopenia (HIT) within the critical care setting and apply this knowledge toward guideline adherence for accurate HIT screening
- Acknowledge expert assessment and current guidelines for accurate HIT diagnosis and utilize this information to support early recognition of its clinical presentation
- Demonstrate awareness of the need for alternative antithrombotic therapy in recognized HIT patients and assess the current clinical evidence surrounding other management options
- Utilize practical tools for raising HIT awareness and improving its management within the critical care setting, in accordance with current guidelines
